Clinical Trials Browser

Phase 1/2 × OTHER × tazarotenic acid × Clear all

NCT00779896 2008-10-24

Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study

Phase 1/2 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous